PubMed Health⌕ Search

PubMed · 12621833

[Molecular imaging].

Abstract

The disclosure of the human genoma, the progress in understanding of diseases on molecular and cellular levels, the discovery of new disease-specific targets, and the development of new medications will revolutionize our understanding of the etiology and the treatment of many disease entities. Radiologists are faced with a paradigm shift from unspecific to specific molecular imaging techniques as well as with enormous speed in the development of new methods and should be enrolled actively in this field of medicine.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Turetschek, P Wunderbaldinger. 2002. [Molecular imaging].. https://pubmed.ncbi.nlm.nih.gov/12621833/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Warm glow, free-riding and vehicle neutrality in a health-related contingent valuation study.

Criticism of contingent valuation (CV) stresses warm glow and free-riding as possible causes for biased willingness to pay figures. We present an empirical framework to study the existence of warm glow and free-riding in hypothetical WTP answers based on a CV survey for the measurement of health-related Red Cross services. Both in conventional double-bounded and spike models we do not find indication of warm glow phenomena and free-riding behaviour. The results are very robust and insensitive to the applied payment vehicles. Theoretical objections against CV do not find sufficient empirical support.

Austria↗

Monitoring of selected estrogenic hormones and industrial chemicals in groundwaters and surface waters in Austria.

In order to address the Austrian situation concerning endocrine disrupting substances (EDS), a consortium called Austrian Research Cooperation on Endocrine Modulators (ARCEM) was established in 1999. Among several other issues that were investigated, ARCEM monitored more than 400 ground- and surface water samples for selected estrogenic hormones and industrial chemicals. Appropriate analytical methods were established using GC-HRMS for the detection of hormones and LC/MSMS for the detection of industrial chemicals. Since analytical results were forwarded for toxicological assessments within the programme, quantification limits below 0.1 ng/l (ethinyl estradiol) and 10 ng/l (industrial chemicals) were required depending on the NOEL of the individual compound. Results indicate that both hormones and industrial chemicals occur in the selected ground- and surface water sites in detectable concentrations. Three river sites were identified as being charged with noticeable concentrations of EDS. These results were verified by biological indications within the part of the ARCEM programme dealing with bio-indications.

Austria↗